European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies Asia Congress 2025

European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies Asia Congress 2025 is organized by European Society for Medical Oncology (ESMO) and will be held from Jul 18 - 20, 2025 at Kerry Hotel, Hong Kong.

Description:
ESMO TAT, the multi-stakeholder forum gathering key actors in cancer drug development, arrives in one of the most dynamic and best-connected hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region. Through in-depth discussions on critical topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy, ESMO TAT Asia aims to drive progress in cancer treatment and research.

Located in the lively city of Hong Kong, ESMO TAT Asia promises to be a vibrant gathering with region’s industry, academia, clinicians, and regulators to promote international cooperation and accelerate the anticancer research.

Come and join us to chart new paths in cancer drug development in Asia.

Learning Objectives:
In the Keynote lectures, Educational sessions, Special sessions with Industry, Scientific sessions and Poster exhibition, attendees will be able to update their knowledge on:

• Innovation in methodologies for early phase drug development
• Novel concepts in preclinical modelling
• New imaging technologies
• Breakthroughs in novel kinase inhibitors, oral immunotherapies, next-generation macromolecules and cell-based therapies
• Methodological and regulatory challenges in the development of new agents
• Multi-stakeholder insights from the oncology and biotechnology industries